Distinguishing acute-onset CIDP from fluctuating Guillain-Barré syndrome
Top Cited Papers
- 25 May 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 74 (21), 1680-1686
- https://doi.org/10.1212/wnl.0b013e3181e07d14
Abstract
Objective: The aim of the study was to provide criteria that can help to distinguish between GBS-TRF and A-CIDP in the early phase of disease. Background: The distinction between Guillain-Barré syndrome (GBS) with fluctuations shortly after start of treatment (treatment-related fluctuations, or GBS-TRF) and chronic inflammatory demyelinating polyneuropathy with acute onset (A-CIDP) is difficult but important because prognosis and treatment strategy largely differ. Methods: Patients with GBS (n = 170) were included in a prospective longitudinal study. Patients with GBS-TRF (n = 16) and patients with A-CIDP (n = 8) were analyzed and compared. Extended clinical data, biologic material, and electrophysiologic data were collected during 1 year follow-up. Results: The first TRF in the GBS-TRF group always occurred within 8 weeks (median 18 days; range 10–54 days) from onset of weakness. In the GBS-TRF group, 5 (31%) patients had a second TRF and none had more TRFs. At all timepoints, patients in the A-CIDP group were less severely affected than patients with GBS-TRF, did not need artificial ventilation, rarely had cranial nerve dysfunction, and tended to have more CIDP-like electrophysiologic abnormalities. More GBS-TRF patients were severely affected and more patients had sensory disturbances when compared to the GBS group without fluctuations. Conclusions: The diagnosis of acute-onset chronic inflammatory demyelinating polyneuropathy (CIDP) should be considered when a patient thought to have Guillain-Barré syndrome deteriorates again after 8 weeks from onset or when deterioration occurs 3 times or more. Especially when the patient remains able to walk independently and has no cranial nerve dysfunction or electrophysiologic features likely to be compatible with CIDP, maintenance treatment for CIDP should be considered.This publication has 27 references indexed in Scilit:
- Recurrent Guillain-Barre syndromeJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Onset and course of chronic inflammatory demyelinating polyneuropathyMuscle & Nerve, 2005
- Akute und chronisch entzündliche Neuropathien - DiagnostikDeutsche Medizinische Wochenschrift (1946), 2003
- Comparison between impairment and disability scales in immune‐mediated polyneuropathiesMuscle & Nerve, 2003
- Manual of Nerve Conduction StudiesJournal of Clinical Neuromuscular Disease, 2000
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 1998
- Risk factors for treatment related clinical fluctuations in Guillain-Barre syndromeJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991
- Treatment related fluctuations in Guillain-Barre syndrome after high-dose immunoglobulins or plasma-exchange.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988